药时代网站（以下简称“本网站”）是由上海凯优文化传播有限公司运营，旨在为用户提供新药研发进展、临床试验分析、BD投融资等相关新闻和信息。用户在使用本网站时，请仔细阅读以下免责声明：
- 信息来源与准确性：本网站所发布的信息均来源于公开渠道，包括但不限于新闻报道、官方公告、科研文献等。尽管我们尽力确保信息的准确性和完整性，但由于信息来源的多样性以及信息的实时性，我们无法对信息的准确性或完整性作出保证。用户在使用本网站提供的信息时，应自行判断其真实性、准确性及适用性。
- 不构成投资建议：本网站发布的BD投融资相关信息仅供参考，不构成任何投资建议。投资有风险，用户在做出投资决策时，应自行评估风险，并谨慎决策。
- 不涉及医疗建议：本网站所发布的新药研发进展和临床试验分析等信息，仅供医疗专业人士和公众参考，并不构成任何医疗建议。对于任何基于本网站信息所做的医疗决策，本网站不承担任何责任。
- 版权声明：本网站尊重他人的知识产权，并尽力确保所发布的信息不侵犯任何第三方的版权。如果您认为本网站上的内容侵犯了您的版权，请与我们联系，我们将尽快处理。
- 免责范围：用户在使用本网站时，应自行承担因使用本网站信息所产生的任何风险。对于因使用本网站信息而引发的任何直接或间接损失，包括但不限于经济损失、名誉损失等，本网站不承担任何法律责任。
- 变更与终止：本网站有权随时变更或终止本免责声明的部分内容或全部内容，而无需提前通知用户。用户在使用本网站时，应定期查看本免责声明，以了解最新的条款和条件。
- 法律适用与争议解决：本免责声明的解释、效力及争议解决均适用中华人民共和国法律。如因本免责声明产生任何争议，双方应首先通过友好协商解决；协商不成的，任何一方均有权向有管辖权的人民法院提起诉讼。
请用户在使用本网站时，仔细阅读并理解本免责声明的全部内容。如有任何疑问，请随时与我们联系。
联系方式:
电话：13651980212
微信：27674131
邮箱：contact@drugtimes.cn
Disclaimer
This website (hereinafter referred to as “the Website”) is operated by Shanghai CareU Culture Communication Co., Ltd. and aims to provide users with news and information related to new drug development progress, clinical trial analysis, BD investment and financing, and more. When using the Website, please carefully read the following disclaimer:
- Information Source and Accuracy: The information published on this Website is sourced from public channels, including but not limited to news reports, official announcements, scientific research literature, etc. While we strive to ensure the accuracy and completeness of the information, due to the diversity of information sources and its real-time nature, we cannot guarantee the accuracy or completeness of the information. Users should independently judge the authenticity, accuracy, and applicability of the information provided on this Website.
- Not Constituting Investment Advice: The BD investment and financing-related information published on this Website is for reference only and does not constitute any investment advice. Investment involves risks, and users should independently assess the risks and make decisions with caution when making investment decisions.
- Not Involving Medical Advice: The new drug development progress and clinical trial analysis information published on this Website is for reference only by medical professionals and the general public and does not constitute any medical advice. The Website shall not be held responsible for any medical decisions made based on the information provided on this Website.
- Copyright Statement: The Website respects the intellectual property rights of others and strives to ensure that the information published does not infringe the copyright of any third party. If you believe that the content on this Website infringes your copyright, please contact us, and we will handle it promptly.
- Scope of Disclaimer: Users shall bear any risks arising from the use of the information provided on this Website. The Website shall not be held liable for any direct or indirect losses, including but not limited to economic losses and reputational losses, caused by the use of the information provided on this Website.
- Changes and Termination: The Website has the right to change or terminate part or all of this disclaimer at any time without prior notice to users. Users should regularly check this disclaimer when using the Website to understand the latest terms and conditions.
- Applicable Law and Dispute Resolution: The interpretation, validity, and dispute resolution of this disclaimer shall be governed by the laws of the People’s Republic of China. If any dispute arises from this disclaimer, both parties shall first resolve it through friendly negotiation; if the negotiation fails, any party has the right to file a lawsuit with the people’s court with jurisdiction.
Please carefully read and understand the entire content of this disclaimer before using the Website. If you have any questions, please feel free to contact us.
TEL：+8613651980212
WeChat：27674131
E-mail：contact@drugtimes.cn
